← Browse by Condition
Medical Condition

t all lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT06909474 Phase 1
Recruiting

Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies

Enrollment
15 pts
Location
China
Sponsor
Chongqing Precision Biotech Co...
View Trial →